5 hours ago
1
mohd izzuan
Johnson & Johnson (NYSE:JNJ) traded higher in the premarket on Wednesday as the healthcare giant started pharma earnings season, lifting its full-year outlook after reporting better-than-expected financials for Q2 2025.
Attributing the guidance raise to favorable forex results and strong
© FBT Company 2025. All rights are reserved
English (US) ·